Trials / Sponsors / Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | VE303 for Prevention of Recurrent Clostridioides Difficile Infection Clostridium Difficile, Clostridium Difficile Infections, Clostridium Difficile Infection Recurrence | Phase 3 | 2024-05-20 |
| Terminated | VE202 in Patients With Mild-to-Moderate Ulcerative Colitis Ulcerative Colitis, Colitis, Ulcerative | Phase 2 | 2023-05-08 |
| Completed | Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer Metastatic Cancer, Melanoma, Gastric Cancer | Phase 1 / Phase 2 | 2020-01-23 |
| Completed | Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Clostridium Difficile | Phase 2 | 2019-02-08 |
| Completed | First-in-human Study of VE303 in Healthy Adult Volunteers Healthy Volunteers | Phase 1 | 2017-11-28 |